蘇州高新(600736.SH):擬對投資管理公司增資3億元
格隆匯11月19日丨蘇州高新(600736.SH)公佈,投資管理公司為公司全資子公司,自運營以來,緊密圍繞公司產業轉型升級目標,設立產業基金、開展直接投資業務等,並以蘇州高新私募基金管理有限公司為申請主體,於2021年7月1日取得基金管理人資格。
為加速公司轉型升級,更好地獲取投資收益,公司擬對投資管理公司增資3億元,增資價格為1.01元/註冊資本份額,其中29702.9703萬元計入註冊資本,297.0297萬元計入資本公積;增資完成後,投資管理公司的註冊資本由30000萬元增至59702.9703萬元。投資管理公司作為公司投資平台,將積極參與產業投資基金、股權投資基金的發起設立。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.